Guidelines Developed for Peri-Op, Post-Op Rhinoplasty Care

Share this content:
Guidelines Developed for Peri-Op, Post-Op Rhinoplasty Care
Guidelines Developed for Peri-Op, Post-Op Rhinoplasty Care

THURSDAY, Feb. 2, 2017 (HealthDay News) -- A new clinical practice guideline, published in the February issue of Otolaryngology-Head and Neck Surgery, offers recommendations for clinicians who perform rhinoplasty and those who are involved in care for rhinoplasty candidates.

Lisa E. Ishii, M.D., from Johns Hopkins University in Baltimore, and colleagues used current evidence-based medicine practices and data to provide recommendations for perioperative and postoperative rhinoplasty care.

The researchers note that all patients seeking rhinoplasty should be asked about their motivations for surgery and expectations for outcomes; this discussion should be documented in the medical record. Rhinoplasty candidates should be assessed for comorbid conditions that could impact surgery. During the preoperative assessment, rhinoplasty candidates should be evaluated for nasal airway obstruction. Candidates for surgery with obstructive sleep apnea should be educated regarding expectations after surgery and perioperative management. Patients should be educated about strategies to manage discomfort after surgery. Patient satisfaction with their nasal appearance and function should be documented at least 12 months after rhinoplasty. Antibiotics administered perioperatively should not be routinely prescribed for a duration >24 hours after surgery; packing should not be routinely placed in the nasal cavity of rhinoplasty patients at the end of surgery.

"The impetus for this guideline is to utilize current evidence-based medicine practices and data to build unanimity regarding the peri- and postoperative strategies to maximize patient safety and to optimize surgical results for patients," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »